Bottom Line: Bristol Myers Squibbs Q3 shows operational strength amid portfolio transition where the commercial success of Cobenfy will hinge not just on efficacy, but on market education, prescriber trust, and psychiatric ecosystem evolution
Some people do experience mild fatigue a few hours after treatment, but don't worrythis is actually a good sign
However, patients commonly experienced gastrointestinal side effects such as nausea, vomiting, diarrhoea, constipation and abdominal pain
All three drugs branded, authorized generic, and generic are therapeutically equivalent, but sometimes theyre available in different doses
dit product is niet bedoeld voor menselijk, therapeutisch, cosmetisch of diagnostisch gebruik
Watch now: